BTMD FINANCIAL STATEMENTS

biote Corp — balance sheet, income statement and cash flow trends

BTMDbiote Corp

🇺🇸 USA · NASDAQ · Healthcare · Medical Care Facilities

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue188.2 M $-5.6%

Gross Profit131.9 M $-6.5%

Operating Income29 M $-8.2%

EBITDA37.3 M $-29.9%

Net Income15.6 M $-28.4%

Peer Comparison· Medical Care Facilities

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
BTMD	-5.6%	70.1%	19.8%	8.3%
LKMNH	19.8%	18.8%	26.4%	3.2%
EGEPO	13.4%	13.2%	15.2%	2.6%
TNZTP	23.8%	40.0%	36.7%	19.0%
RYM	215.1%	-5.9%	-21.8%	-60.1%
SNZ	13.3%	42.8%	47.9%	72.0%
Industry median	10.2%	27.7%	13.8%	3.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
BTMD	-5.6%	70.1%	19.8%	8.3%
PIII	-0.9%	50.6%	-9.4%	-8.6%
DCGO	-42.0%	29.5%	-51.8%	-62.2%
JYNT	221.8%	79.9%	5.2%	5.7%
WW	-9.6%	68.7%	178.5%	155.5%
AIRS	-11.8%	60.6%	2.8%	-7.4%
Industry median	10.2%	27.7%	13.8%	3.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Current Liabilities28.2 M $21%
Long-term Liabilities108.8 M $79%

Key Figures

YoY change

Total Assets89 M $-27.8%

Total Liabilities137 M $-34.2%

Total Equity-56.1 M $—

Cash & ST Investments5.3 M $-87.2%

Total Debt108.4 M $-0.9%

Net Debt103.1 M $+52.3%

Peer Comparison· Medical Care Facilities

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
BTMD	1.29	-193.3%	2.77	-63.0%
LKMNH	0.83	99.0%	1.96	41.6%
EGEPO	1.76	2.0%	-0.67	82.7%
TNZTP	2.37	9.2%	-0.40	79.7%
RYM	0.55	39.0%	-6.24	33.2%
SNZ	0.34	59.6%	11.44	36.0%
Industry median	1.26	59.9%	1.87	35.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
BTMD	1.29	-193.3%	2.77	-63.0%
PIII	0.33	-43.4%	-0.27	-21.3%
DCGO	1.79	21.5%	0.05	63.2%
JYNT	1.61	13.2%	-6.59	26.7%
WW	1.19	176.3%	0.28	30.1%
AIRS	0.75	70.8%	12.57	52.2%
Industry median	1.26	59.9%	1.87	35.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow32.6 M $-26.4%

Capital Expenditures4.7 M $-37.0%

Free Cash Flow27.9 M $-24.2%

Dividends Paid1.4 M $-84.2%

Peer Comparison· Medical Care Facilities

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
BTMD	17.3%	14.8%	2.5%	209.1%
LKMNH	8.4%	-9.7%	18.2%	264.8%
EGEPO	1.5%	-11.8%	10.9%	55.7%
TNZTP	20.2%	53.5%	7.6%	106.1%
RYM	36.5%	31.3%	5.2%	-60.7%
SNZ	137.8%	87.4%	50.4%	191.5%
Industry median	10.4%	5.8%	3.6%	165.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
BTMD	17.3%	14.8%	2.5%	209.1%
PIII	-5.8%	-5.8%	0.0%	67.5%
DCGO	-1,543,776.9%	-1,686,400.7%	142,623.8%	2,480,744.4%
JYNT	7.2%	4.7%	2.5%	125.5%
WW	-11.2%	-14.1%	2.9%	-7.2%
AIRS	4.9%	4.6%	0.4%	-66.9%
Industry median	10.4%	5.8%	3.6%	165.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BTMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.